Sanara Medtech Inc
NASDAQ:SMTI

Watchlist Manager
Sanara Medtech Inc Logo
Sanara Medtech Inc
NASDAQ:SMTI
Watchlist
Price: 29.65 USD -0.97% Market Closed
Market Cap: 263.6m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+83%
Revenue
Forecast
-2%
Operating Income
Forecast
+5%
Net Income
Forecast
+13%

Wall Street
Price Targets

SMTI Price Targets Summary
Sanara Medtech Inc

Wall Street analysts forecast SMTI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SMTI is 49.98 USD with a low forecast of 45.45 USD and a high forecast of 55.65 USD.

SMTI Lowest Forecast
Wall Street Target
45.45 USD
53% Upside
SMTI Average Forecast
Wall Street Target
49.98 USD
69% Upside
SMTI Highest Forecast
Wall Street Target
55.65 USD
88% Upside
Lowest
Price Target
45.45 USD
53% Upside
Average
Price Target
49.98 USD
69% Upside
Highest
Price Target
55.65 USD
88% Upside
Sanara Medtech Inc Competitors:
Price Targets
ALGN
Align Technology Inc
17% Upside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
33% Upside
P
6491
Pegavision Corp
25% Upside
1066
Shandong Weigao Group Medical Polymer Co Ltd
7% Upside
ALGN
Align Technology Inc
17% Upside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
33% Upside
P
6491
Pegavision Corp
25% Upside
1066
Shandong Weigao Group Medical Polymer Co Ltd
7% Upside
XVIVO
Xvivo Perfusion AB
59% Upside
H
HARTA
Hartalega Holdings Bhd
64% Upside
FIGS
Figs Inc
20% Downside
POLYMED
Poly Medicure Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Sanara Medtech Inc

For the last 8 years the compound annual growth rate for Sanara Medtech Inc's revenue is 41%. The projected CAGR for the next 2 years is 14%.

41%
Past Growth
14%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sanara Medtech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sanara Medtech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
SMTI intrinsic value, competitors valuation, and company profile.
DCF Valuation
SMTI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SMTI stock valuation using valuation multiples.
Wall Street Estimates
SMTI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SMTI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMTI's stock price target?
Price Target
49.98 USD

According to Wall Street analysts, the average 1-year price target for SMTI is 49.98 USD with a low forecast of 45.45 USD and a high forecast of 55.65 USD.

What is Sanara Medtech Inc's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Sanara Medtech Inc's revenue is 41%. The projected CAGR for the next 2 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 265,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.